AP2002002673A0 - Thiazolidinedione salt for the treatment of diabetes mellitus. - Google Patents

Thiazolidinedione salt for the treatment of diabetes mellitus.

Info

Publication number
AP2002002673A0
AP2002002673A0 APAP/P/2002/002673A AP2002002673A AP2002002673A0 AP 2002002673 A0 AP2002002673 A0 AP 2002002673A0 AP 2002002673 A AP2002002673 A AP 2002002673A AP 2002002673 A0 AP2002002673 A0 AP 2002002673A0
Authority
AP
ARIPO
Prior art keywords
treatment
diabetes mellitus
compound
thiazolidinedione
salt
Prior art date
Application number
APAP/P/2002/002673A
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AP2002002673A0 publication Critical patent/AP2002002673A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
APAP/P/2002/002673A 2000-06-08 2001-06-08 Thiazolidinedione salt for the treatment of diabetes mellitus. AP2002002673A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
PCT/GB2001/002567 WO2001094344A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
AP2002002673A0 true AP2002002673A0 (en) 2002-12-31

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2002/002673A AP2002002673A0 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for the treatment of diabetes mellitus.

Country Status (23)

Country Link
EP (1) EP1296980A1 (no)
JP (1) JP2003535862A (no)
KR (1) KR20030007918A (no)
CN (1) CN1443186A (no)
AP (1) AP2002002673A0 (no)
AU (1) AU2001264078A1 (no)
BG (1) BG107357A (no)
BR (1) BR0111536A (no)
CA (1) CA2411065A1 (no)
CZ (1) CZ20023966A3 (no)
DZ (1) DZ3382A1 (no)
EA (1) EA200300005A1 (no)
GB (1) GB0014006D0 (no)
HU (1) HUP0301137A3 (no)
IL (1) IL153279A0 (no)
MA (1) MA25753A1 (no)
MX (1) MXPA02012100A (no)
NO (1) NO20025883L (no)
OA (1) OA12284A (no)
PL (1) PL360592A1 (no)
SK (1) SK17142002A3 (no)
WO (1) WO2001094344A1 (no)
ZA (1) ZA200209954B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US20080176905A1 (en) * 2007-01-22 2008-07-24 Santiago Ini Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (de) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung eines Benzimidazolderivats
WO2010021745A2 (en) * 2008-08-21 2010-02-25 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
HUP0301137A3 (en) 2005-04-28
HUP0301137A2 (hu) 2003-08-28
AU2001264078A1 (en) 2001-12-17
PL360592A1 (en) 2004-09-20
BR0111536A (pt) 2003-07-01
JP2003535862A (ja) 2003-12-02
DZ3382A1 (fr) 2001-12-13
MXPA02012100A (es) 2003-04-25
CN1443186A (zh) 2003-09-17
GB0014006D0 (en) 2000-08-02
BG107357A (bg) 2003-08-29
NO20025883D0 (no) 2002-12-06
ZA200209954B (en) 2003-10-10
EA200300005A1 (ru) 2003-04-24
EP1296980A1 (en) 2003-04-02
CZ20023966A3 (cs) 2003-04-16
NO20025883L (no) 2003-02-03
OA12284A (en) 2003-11-10
CA2411065A1 (en) 2001-12-13
KR20030007918A (ko) 2003-01-23
WO2001094344A1 (en) 2001-12-13
IL153279A0 (en) 2003-07-06
SK17142002A3 (sk) 2003-10-07
MA25753A1 (fr) 2003-04-01

Similar Documents

Publication Publication Date Title
AP2002002673A0 (en) Thiazolidinedione salt for the treatment of diabetes mellitus.
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
WO2000063205A3 (en) Thiazolidinedione derivative and its use as antidiabetic
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
YU16303A (sh) Tartaratne soli derivata tiazolidindiona
DK1349855T3 (da) 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt
HK1057204A1 (en) A thiazolidinedione derivative and its use as antidiabetic
AP1680A (en) Thiazolidinedione derivative and its use as antidiabetic.
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
PT1446404E (pt) Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
AP1841A (en) A thiazolidinedione derivative and its use as antidiabetic.
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt
NZ524933A (en) Sodium salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical composition thereof
AP1813A (en) Tartrate salts of thiazolidinedione derivative.